Form 4: Accelerate Diagnostics Director, Jennifer Regan, Receives 66,667 Restricted Stock Units

Director Jennifer Regan was granted 66,667 restricted stock units (RSUs) in Accelerate Diagnostics, Inc. on May 20, 2024, which vest on the first anniversary of the grant date.

Summary

• Jennifer Regan, a director of Accelerate Diagnostics, Inc., received 66,667 restricted stock units (RSUs) on May 20, 2024.
• Each RSU represents the right to receive one share of Accelerate Diagnostics' common stock upon vesting.
• The RSUs vest on the first anniversary of the grant date, provided the reporting person remains in good standing.
• If the reporting person leaves in good standing before the vesting date, the RSUs will vest pro-rata based on months served.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management interests with shareholder value.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing her to contribute to the company's long-term success.

Future Outlook

The RSUs will vest on the first anniversary of the grant date, contingent on continued service.

Industry Context

Granting stock options and RSUs to directors is a common practice to align their interests with those of the shareholders and incentivize long-term value creation.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it incentivizes the director to work towards increasing shareholder value.

Key Dates